Concepedia

Author

Gregory T. Klus

University of Maryland, Baltimore

Also Known As

G T Klus, G. T. KLUS, GREGORY T. KLUS, Gregory Klus, Gregory T Klus, Gregory T. Klus

14

Publications

387

Citations

9

H-Index

31

Concepts

All Affiliations

University of Maryland, BaltimoreCenter for Cancer ResearchNational Cancer Institute
GT

About

Gregory T. Klus is an author at University of Maryland, Baltimore specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

149

2

Biochemistry

3

3

86

3

Natural Sciences

2

2

70

4

Cell Biology

2

2

101

5

Endocrinology

1

1

32

Gregory T. Klus

×

8

Publications

358

Citations

8

H-Index

YearCitations

17-Imidazolyl, Pyrazolyl, and Isoxazolyl Androstene Derivatives. Novel Steroidal Inhibitors of Human Cytochrome C<sub>l7,20</sub>-Lyase (P450<sub>17α</sub>)

Yangzhi Ling, Ji-song Li, Liu Yang,

Journal of Medicinal Chemistry

1997

111

Near‐tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness

Darawalee Wangsa, Isabel Quintanilla, Keyvan Torabi,

The FASEB Journal

2018

68

Nucleophilic vinylic “addition-elimination” substitution reaction of 3β-acetoxy-17-chloro-16-formylandrosta-5,16-diene: A novel and general route to 17-substituted steroids. Part 1 - synthesis of novel 17-azolyl-Δ16 steroids; inhibitors of 17α-hydroxylase/17, 20-lyase (17α-lyase)

Vincent C.O. Njar, Gregory T. Klus, Angela Brodie

Bioorganic & Medicinal Chemistry Letters

1996

38

Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer

Gregory T. Klus, Nina Rökaeus, Michael Bittner,

International Journal of Oncology

2001

33

Synthesis and in vitro activity of some epimeric 20α-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17α-hydroxylase/c17,20-lyase and 5α-reductase

Yangzhi Ling, Ji-song Li, Katsuya Kato,

Bioorganic & Medicinal Chemistry

1998

33

Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.

Gregory T. Klus, Jun-ichi Nakamura, Ji-song Li,

PubMed

1996

32

Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts

Ádám Póti, Kinga Berta, Yonghong Xiao,

British Journal of Cancer

2018

27

Synthesis of novel 21-trifluoropregnane steroids: Inhibitors of 17α-hydroxylase/17,20-lyase (17α-lyase)

Vincent C.O. Njar, Gregory T. Klus, Hausa H. Johnson,

Steroids

1997

16

Page 1